188 related articles for article (PubMed ID: 7515974)
1. Unprocessed foot-and-mouth disease virus capsid precursor displays discontinuous epitopes involved in viral neutralization.
Sáiz JC; Cairó J; Medina M; Zuidema D; Abrams C; Belsham GJ; Domingo E; Vlak JM
J Virol; 1994 Jul; 68(7):4557-64. PubMed ID: 7515974
[TBL] [Abstract][Full Text] [Related]
2. Mutational analysis of discontinuous epitopes of foot-and-mouth disease virus using an unprocessed capsid protomer precursor.
Mateu MG; Escarmís C; Domingo E
Virus Res; 1998 Jan; 53(1):27-37. PubMed ID: 9617767
[TBL] [Abstract][Full Text] [Related]
3. Monoclonal antibodies to an Indian strain of type A foot-and-mouth disease virus.
Tosh C; Venkataramanan R; Pattnaik B; Hemadri D; Sanyal A
Acta Virol; 1999 Aug; 43(4):219-25. PubMed ID: 10749367
[TBL] [Abstract][Full Text] [Related]
4. Expression, processing, and assembly of foot-and-mouth disease virus capsid structures in heterologous systems: induction of a neutralizing antibody response in guinea pigs.
Lewis SA; Morgan DO; Grubman MJ
J Virol; 1991 Dec; 65(12):6572-80. PubMed ID: 1658362
[TBL] [Abstract][Full Text] [Related]
5. Immunogenicity of an aphthovirus chimera of the glycoprotein of vesicular stomatitis virus.
Grigera PR; Garcia-Briones M; Periolo O; la Torre JL; Wagner RR
J Virol; 1996 Dec; 70(12):8492-501. PubMed ID: 8970972
[TBL] [Abstract][Full Text] [Related]
6. Identification of neutralizing antigenic sites on VP1 and VP2 of type A5 foot-and-mouth disease virus, defined by neutralization-resistant variants.
Saiz JC; Gonzalez MJ; Borca MV; Sobrino F; Moore DM
J Virol; 1991 May; 65(5):2518-24. PubMed ID: 1707983
[TBL] [Abstract][Full Text] [Related]
7. Analysis of neutralizing epitopes on foot-and-mouth disease virus.
Pfaff E; Thiel HJ; Beck E; Strohmaier K; Schaller H
J Virol; 1988 Jun; 62(6):2033-40. PubMed ID: 2835507
[TBL] [Abstract][Full Text] [Related]
8. Antigenic comparison of different foot-and-mouth disease virus types using monoclonal antibodies defining multiple neutralizing epitopes on FMDV A5 subtypes.
Saiz JC; Gonzalez MJ; Morgan DO; Card JL; Sobrino F; Moore DM
Virus Res; 1989 May; 13(1):45-60. PubMed ID: 2473578
[TBL] [Abstract][Full Text] [Related]
9. Modified-live infectious bovine rhinotracheitis virus vaccine expressing monomer and dimer forms of foot-and-mouth disease capsid protein epitopes on surface of hybrid virus particles.
Kit S; Kit M; DiMarchi RD; Little SP; Gale C
Arch Virol; 1991; 120(1-2):1-17. PubMed ID: 1718244
[TBL] [Abstract][Full Text] [Related]
10. Myristoylation of foot-and-mouth disease virus capsid protein precursors is independent of other viral proteins and occurs in both mammalian and insect cells.
Belsham GJ; Abrams CC; King AM; Roosien J; Vlak JM
J Gen Virol; 1991 Mar; 72 ( Pt 3)():747-51. PubMed ID: 1848606
[TBL] [Abstract][Full Text] [Related]
11. Assembly of foot-and-mouth disease virus empty capsids synthesized by a vaccinia virus expression system.
Abrams CC; King AM; Belsham GJ
J Gen Virol; 1995 Dec; 76 ( Pt 12)():3089-98. PubMed ID: 8847514
[TBL] [Abstract][Full Text] [Related]
12. Development of replication-defective adenovirus serotype 5 containing the capsid and 3C protease coding regions of foot-and-mouth disease virus as a vaccine candidate.
Mayr GA; Chinsangaram J; Grubman MJ
Virology; 1999 Oct; 263(2):496-506. PubMed ID: 10544121
[TBL] [Abstract][Full Text] [Related]
13. Bovine herpesvirus-1 (infectious bovine rhinotracheitis virus)-based viral vector which expresses foot-and-mouth disease epitopes.
Kit M; Kit S; Little SP; Di Marchi RD; Gale C
Vaccine; 1991 Aug; 9(8):564-72. PubMed ID: 1722936
[TBL] [Abstract][Full Text] [Related]
14. Induction of a protective response in swine vaccinated with DNA encoding foot-and-mouth disease virus empty capsid proteins and the 3D RNA polymerase.
Cedillo-Barrón L; Foster-Cuevas M; Belsham GJ; Lefèvre F; Parkhouse RME
J Gen Virol; 2001 Jul; 82(Pt 7):1713-1724. PubMed ID: 11413383
[TBL] [Abstract][Full Text] [Related]
15. Novel expression of immunogenic foot-and-mouth disease virus-like particles in Nicotiana benthamiana.
Veerapen VP; van Zyl AR; Wigdorovitz A; Rybicki EP; Meyers AE
Virus Res; 2018 Jan; 244():213-217. PubMed ID: 29196195
[TBL] [Abstract][Full Text] [Related]
16. Neutralizing epitopes of type O foot-and-mouth disease virus. II. Mapping three conformational sites with synthetic peptide reagents.
Parry NR; Barnett PV; Ouldridge EJ; Rowlands DJ; Brown F
J Gen Virol; 1989 Jun; 70 ( Pt 6)():1493-503. PubMed ID: 2471812
[TBL] [Abstract][Full Text] [Related]
17. A single amino acid substitution affects multiple overlapping epitopes in the major antigenic site of foot-and-mouth disease virus of serotype C.
Mateu MG; Martínez MA; Capucci L; Andreu D; Giralt E; Sobrino F; Brocchi E; Domingo E
J Gen Virol; 1990 Mar; 71 ( Pt 3)():629-37. PubMed ID: 1690261
[TBL] [Abstract][Full Text] [Related]
18. Antibody response in mice inoculated with DNA expressing foot-and-mouth disease virus capsid proteins.
Chinsangaram J; Beard C; Mason PW; Zellner MK; Ward G; Grubman MJ
J Virol; 1998 May; 72(5):4454-7. PubMed ID: 9557740
[TBL] [Abstract][Full Text] [Related]
19. Synthesis of foot-and-mouth disease virus capsid proteins in insect cells using baculovirus expression vectors.
Roosien J; Belsham GJ; Ryan MD; King AM; Vlak JM
J Gen Virol; 1990 Aug; 71 ( Pt 8)():1703-11. PubMed ID: 2167924
[TBL] [Abstract][Full Text] [Related]
20. Reactivity with monoclonal antibodies of viruses from an episode of foot-and-mouth disease.
Mateu MG; Rocha E; Vicente O; Vayreda F; Navalpotro C; Andreu D; Pedroso E; Giralt E; Enjuanes L; Domingo E
Virus Res; 1987 Sep; 8(3):261-74. PubMed ID: 2446442
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
